Catalyst Wire Dossier Catalyst Wire Dossier

Clindamycin gel 1%

clindamycin · Akorn, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clindamycin gel 1%, covering 2020-10-05 to 2020-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris [Phase 3]

See pricing